At the beginning of the year, YPOG provided legal support for a number of significant financing rounds and transactions in the areas of cybersecurity, climate tech, health tech and digital infrastructure solutions. This included advising companies and investors such as Antler, alfa8 Investments, Peak, amberra, Join Capital, the Amadeus APEX Technology Fund, Sensorberg und EquityPitcher.
YPOG advises Antler on NetBird's Series A financing round
Berlin, January 14, 2026 – YPOG has advised investor Antler in connection with the Series A financing round of Berlin-based cybersecurity company NetBird. The financing round is in the single-digit million range and was led by Pace Capital, with participation from other international investors.
NetBird is a Zero Trust networking platform offering a European open-source alternative to traditional VPNs, built to meet modern security and infrastructure requirements. The approach is based on open architecture, product-driven growth, and a strong developer community. The technology addresses key requirements for secure, scalable IT infrastructures in increasingly distributed working environments.
With the fresh capital, NetBird plans to drive forward the further development of its platform, tap into new use cases, and accelerate the growth of its international customer base.
YPOG regularly advises Antler on venture capital transactions and financing rounds in technology-driven markets – previously, for example, on Peec AI's Series A financing round.
Team
Dr. Benjamin Ullrich (Lead, Transactions), Partner, Berlin
Benjamin von Mangoldt (Transactions), Associate, Berlin
Silke Ricken (Corporate), Associate, Berlin
YPOG advises alfa8 Investments on the sale of Klima.Metrix to ESG Software
Cologne, January 16, 2026 – YPOG has advised alfa8 Investments Ltd. on the sale of Klima.Metrix GmbH to ESG Software GmbH. The transaction complements the service portfolio of ESG Software GmbH and its Climcycle brand in the field of digital solutions for climate, environmental, and ESG risk management.
Berlin-based Klima.Metrix GmbH develops software solutions for the automated calculation of company-related CO₂ emissions (Scope 1-3) and for ESG reporting for companies and financial institutions. The technology expands the existing Climcycle platform, in particular with functions for calculating emissions at the company level, and complements the analysis of financed emissions.
The acquisition takes place against the backdrop of increasing regulatory requirements for climate risk analysis and ESG compliance and contributes to the further integration of emissions calculation, risk assessment, and reporting in a unified platform.
Team
Dr. Johannes Janning (Lead, Transactions), Partner, Cologne
Dr. Tim Walter (Transactions), Senior Associate, Cologne
YPOG advises investors Peak and amberra on EUR 8.5 million Series A financing round of healthtech startup Gardia
Cologne, February 6, 2026 – YPOG has advised investors Peak and amberra on the EUR 8.5 million Series A financing round of Soest-based healthtech startup Gardia. The round was led by European venture capital investor Peak, with participation from amberra, butterfly & elephant, as well as existing investors BONVENTURE, Dieter von Holtzbrinck Ventures (DvH Ventures), Beurer and several business angels.
Gardia develops a mobile emergency call system for senior citizens that is specifically tailored to the requirements of a self-determined life in older age. At the heart of the solution is an emergency wristband with automatic fall detection that functions without a smartphone and can be used both at home and on the go. The system is intended to significantly increase the safety of older people and to reduce the consequences of the millions of falls that occur among seniors every year.
With the fresh capital, Gardia plans to further expand its market presence in the DACH region, pursue international expansion and deepen cooperation within the care and healthcare sector. Gardia already works with Bosch Service Solutions to ensure integrated 24/7 emergency call support, enabling rapid and professional assistance in the event of an emergency.
amberra – the corporate venturing studio of the German Cooperative Financial Group Volksbanken Raiffeisenbanken – was previously advised by YPOG on the structuring of the amberra fund and has since relied on YPOG’s legal expertise in numerous venture capital investments.
Team
Dr. Johannes Janning (Lead, Transactions), Partner, Cologne
Janic Salcedas (Transactions), Associate, Cologne
Dr. Tim Walter (Transactions), Senior Associate, Cologne
Laura Franke (Transactions), Senior Project Lawyer, Cologne
Paul Harenberg (Transactions), Associate, Cologne
YPOG advises Join Capital and APEX on EUR 4.1 million seed financing round of Berlin-based cybersecurity startup enclaive
Berlin, February 6, 2026 – YPOG has comprehensively provided legal advice to the venture capital investors Join Capital and Amadeus APEX Technology Fund on their participation in a seed financing round of the Berlin-based cybersecurity company enclaive. The deeptech startup is securing a total of EUR 4.1 million in this round, which was co-led by Join Capital and Amadeus APEX Technology Fund, with participation from Auriga Cyber Ventures.
Enclaive is developing a multi-cloud platform for confidential computing that enables companies to protect sensitive data and applications across different cloud environments without having to adapt existing code, tools or processes. The new funds will be used in particular to expand sales and marketing, further develop the enclaive Multi Cloud Platform (eMCP), grow the team in the engineering and operations areas, and drive international expansion.
Join Capital is a pan-European venture capital firm focused on early-stage investments in deep tech and dual-use technologies backing mission-critical innovations across the industrial, enterprise, and defense sectors to strengthen European sovereignty and resilience. The Amadeus APEX Technology Fund invests in high-growth technology companies, including in the areas of AI, cybersecurity, next-gen computing, space, medical technologies and energy, with a focus on scalable business models geared towards international markets.
Team
Dr. Emma Peters (Co-Lead, Transactions), Associated Partner, Berlin
Dr. Benjamin Ullrich (Co-Lead, Transactions), Partner, Berlin
Dr. Benedikt Flöter (IP/IT/Data Protection), Partner, Berlin
Anna Eickmeier (IP/IT/Data Protection), Associated Partner, Berlin
Charlotte Petrasch (IP/IT/Data Protection), Associate, Berlin
Silke Ricken (Corporate), Associate, Berlin
YPOG advises Sensorberg on second closing of growth financing
Berlin, February 9, 2026 – YPOG has advised Sensorberg GmbH in connection with a seven-digit second closing of its Series C financing round.
Sensorberg, based in Berlin, is a provider of digital access and security solutions for the self-storage industry. The company develops technology-based systems that enable operators to manage their locations more securely, efficiently, and easily. Sensorberg's solutions support the ongoing digitalization of the industry and address requirements for access control, security, and operational efficiency in particular.
With the second closing Sensorberg has laid a solid foundation for driving forward further product development, international market expansion, and team growth.
Team
Dr. Johannes Janning (Lead, Transactions), Partner, Cologne
Janic Salcedas (Transactions), Associate, Cologne
Laura Franke (Transactions), Senior Project Lawyer, Cologne
YPOG advises EquityPitcher on EUR 6 million financing round in hellomed
Hamburg, February 12, 2026 – YPOG has provided comprehensive legal advice to the Swiss venture capital investor EquityPitcher in connection with a EUR 6 million financing round in the Berlin-based healthtech company hellomed Group GmbH.
hellomed has developed “hellomedOS,” a digital platform for medication management that is used nationwide in both outpatient and inpatient care. The company’s mission is to systematically prevent medication errors in care facilities and relieve nursing staff by several hours per patient each week. The platform handles both medication delivery and communication with all parties involved – from general practitioners and pharmacies to care facilities and patients. In Germany, medication errors are estimated to cause up to 250,000 hospital admissions each year.
The current round is led by EquityPitcher Ventures, with participation from IBB Ventures and zwei.7. In addition, over the past two years, several well-known founders, business angels, and family offices from the German startup ecosystem as well as the healthcare and care sectors have already invested in hellomed – an engagement that is now being disclosed for the first time. The fresh capital will be used to scale the company’s reach from currently around 100 to over 2,000 care providers by 2030.
Team
Dr. Adrian Haase (Lead, Transactions), Partner, Hamburg
Dr. Miriam Peer (Transactions), Associate, Hamburg
Dr. Carolin Raspé (Corporate Crime + Compliance + Investigations), Partner, Munich
Laura Püschel (Corporate Crime + Compliance + Investigations), Associate, Munich
Dr. Lutz Schreiber (IP/IT/Data Protection), Partner, Hamburg
Dr. Florian Wittner (IP/IT/Data Protection), Associate, Hamburg
Martin Acker (Tax), Associate, Hamburg